This clinical trial studies how well a long-term follow-up works in patients with prostate cancer after surgery. Long-term follow-up data may serve as a resource to help ask clinical questions, describe health-related quality of life and long-term complications related, and facilitate future studies focusing on interventions to improve health status and health-related quality of life in prostate cancer survivors.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
HRQL assessed using Expanded Prostate Cancer Index Composite
Timeframe: Up to 10 years
HRQL assessed using Sexual Health Inventory for Men
Timeframe: Up to 10 years
Incidence rates of the study end-points
Timeframe: Up to 10 years